Cited by 2,824Immune Cell Function and InteractionReproductive System and PregnancyImmune cells in cancer

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Innate or Adaptive Immunity? The Example of Natural Killer Cells

Open access

Vivier, Eric, Raulet, David H., Moretta, Alessandro, Caligiuri, Michael A., Zitvogel, Laurence, Lanier, Lewis L., Yokoyama, Wayne M., Ugolini, Sophie·2011·Science

DOI 10.1126/science.1198687PMC PMC3089969

Open this paper in CoChat — free account

Abstract

Natural killer (NK) cells were originally defined as effector lymphocytes of innate immunity endowed with constitutive cytolytic functions. More recently, a more nuanced view of NK cells has emerged. NK cells are now recognized to express a repertoire of activating and inhibitory receptors that is calibrated to ensure self-tolerance while allowing efficacy against assaults such as viral infection and tumor development. Moreover, NK cells do not react in an invariant manner but rather adapt to their environment. Finally, recent studies have unveiled that NK cells can also mount a form of antigen-specific immunologic memory. NK cells thus exert sophisticated biological functions that are attributes of both innate and adaptive immunity, blurring the functional borders between these two arms of the immune response.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/science.1198687

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
NK CELL RECOGNITION
Lanier, L. L. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,765
Self-citation
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,333
Human natural killer cells
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,980
Self-citation
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
Miller, J. S., Soignier, Y., Panoskaltsis‐Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D. H., Le, C. T., DeFor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,894
„Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype
Kiessling, R. W., Klein, E., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050208 · Cited by 1,827
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,773
Self-citation
Adaptive Immune Features of Natural Killer Cells
Sun, J. C., Beilke, J., & Lanier, L. (2009) · Nature · doi:10.1038/nature07665 · Cited by 1,647
Self-citation
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity
Herberman, R. B., Nunn, M. E., & Lavrin, D. H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910160204 · Cited by 1,356
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martin‐Fontecha, A., Thomsen, L. L., Brett, S. J., Gerard, C. J., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,351

Flagged first, then by citations

Show all 78 references

Sorted by citations

Items 901–1,000 of 1,003

Natural killer cell engineering for cellular therapy of cancer
Shook, D. R., & Campana, D. (2011) · Tissue Antigens · doi:10.1111/j.1399-0039.2011.01796.x · Cited by 39
Natural killer cells suppress enzalutamide resistance and cell invasion in the castration resistant prostate cancer via targeting the androgen receptor splicing variant 7 (ARv7)
Lin, S.-J., Chou, F.-J., Li, L., Lin, C.-Y., Yeh, S., & Chang, C. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.035 · Cited by 39
Group 2 innate lymphocytes at the interface between innate and adaptive immunity
Schuijs, M. J., & Halim, T. Y. F. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13604 · Cited by 40
Late Development of FcεRγneg Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation Recipients
Muccio, L., Falco, M., Bertaina, A., Locatelli, F., Frassoni, F., Sivori, S., Moretta, L., Moretta, A., & Chiesa, M. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01050 · Cited by 39
Self-citation
Optimizing NK-92 serial killers: gamma irradiation, CD95/Fas-ligation, and NK or LAK attack limit cytotoxic efficacy
Navarrete-Galvan, L. T., Guglielmo, M. J., Amaya, J. B. C., Smith‐Gagen, J., Lombardi, V. C., Merica, R. R., & Hudig, D. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03350-6 · Cited by 39
Long-acting vaccine delivery systems
Walvekar, P., Kumar, P., & Choonara, Y. E. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114897 · Cited by 39
Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism
Torres, A. R., Westover, J. B., Gibbons, C., Johnson, R. C., & Ward, D. C. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.07.014 · Cited by 41
KIR and HLA Genotypes Predictive of Low-Affinity Interactions Are Associated with Lower Relapse in Autologous Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
Marra, J. D., Greene, J., Hwang, J. J., Du, J., Damon, L. E., Martin, T. G., & Venstrom, J. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402124 · Cited by 39
Diversity, function, and transcriptional regulation of gut innate lymphocytes
Rankin, L. C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00022 · Cited by 42
CAR-NK cells in combination therapy against cancer: A potential paradigm
Li, J., Hu, H., Lian, K., Zhang, D., Hu, P., He, Z., Zhang, Z., & Wang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27196 · Cited by 40
Altered distribution and function of natural killer cells in murine and human Niemann-Pick disease type C1
Speak, A. O., Vruchte, D. T., Davis, L. C., Morgan, A. J., Smith, D. A., Yanjanin, N. M., Simmons, L., Hartung, R., Runz, H., Mengel, E., et al. (2013) · Blood · doi:10.1182/blood-2013-03-488692 · Cited by 39
Immune Response in Thyroid Cancer: Widening the Boundaries
Ward, L. S. (2014) · Scientifica · doi:10.1155/2014/125450 · Cited by 40
Human Immunodeficiency Syndromes Affecting Human Natural Killer Cell Cytolytic Activity
Ham, H., & Billadeau, D. D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00002 · Cited by 39
Endothelial monolayers and transendothelial migration depend on mechanical properties of the substrate
Onken, M. D., Mooren, O. L., Mukherjee, S., Shahan, S. T., Li, J., & Cooper, J. A. (2014) · Cytoskeleton · doi:10.1002/cm.21203 · Cited by 38
The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity
Duev‐Cohen, A., Bar‐On, Y., Glasner, A., Berhani, O., Ophir, Y., Levi‐Schaffer, F., Mandelboim, M., & Mandelboim, O. (2016) · Oncotarget · doi:10.18632/oncotarget.7597 · Cited by 39
The Human Immune Response
Rich, R. R., & Chaplin, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00001-6 · Cited by 38
Nectin spot: a novel type of nectin-mediated cell adhesion apparatus
Mizutani, K., & Takai, Y. (2016) · Biochemical Journal · doi:10.1042/bcj20160235 · Cited by 38
The role of innate lymphoid cells in health and disease
Mohammadi, H., Sharafkandi, N., Hemmatzadeh, M., Azizi, G., Karimi, M. H., Jadidi‐Niaragh, F., Baradaran, B., & Babaloo, Z. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26250 · Cited by 42
Helper-like innate lymphoid cells and cancer immunotherapy
Crinier, A., Vivier, É., & Bléry, M. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.04.002 · Cited by 37
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
Yoon, J. S., Song, B. G., Lee, J., Lee, H. Y., Kim, S. W., Chang, Y. W., Lee, Y. B., Cho, E. J., Yu, S. J., Sinn, D. H., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5740-z · Cited by 38
NK Cell-Based Immunotherapy in Renal Cell Carcinoma
Terrén, I., Orrantia, A., Mikelez-Alonso, I., Vitallé, J., Zenarruzabeitia, O., & Borrego, F. (2020) · Cancers · doi:10.3390/cancers12020316 · Cited by 40
Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells
Polidoro, M. A., Mikulak, J., Cazzetta, V., Lleò, A., Mavilio, D., Torzilli, G., & Donadon, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i33.4900 · Cited by 41
The impact of distributed time delay in a tumor-immune interaction system
Sardar, M., Biswas, S., & Khajanchi, S. (2020) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2020.110483 · Cited by 38
Immunotherapeutic Strategies for Neuroblastoma: Present, Past and Future
Morandi, F., Sabatini, F., Podestà, M., & Airoldi, I. (2021) · Vaccines · doi:10.3390/vaccines9010043 · Cited by 37
Natural killer cells in first-episode psychosis: an innate immune signature?
Tarantino, N., Leboyer, M., Bouleau, A., Hamdani, N., Richard, J., Boukouaci, W., Wu, C., Godin, O., Bengoufa, D., Corvoisier, P. L., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-01008-7 · Cited by 39
Natural Killer Cells in Cancer and Cancer Immunotherapy
Raskov, H., Orhan, A., Salanti, A., Gaggar, S., & Gögenür, I. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.032 · Cited by 39
Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review)
Zeng, Y., Lv, X., & Du, J. (2021) · Oncology Reports · doi:10.3892/or.2021.8183 · Cited by 38
Role of the ITAM-Bearing Receptors Expressed by Natural Killer Cells in Cancer
Khlifi, H. M., Guia, S., Vivier, É., & Narni-Mancinelli, É. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.898745 · Cited by 41
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment
Parodi, M., Pedrazzi, M., Cantoni, C., Averna, M., Patrone, M., Cavaletto, M., Spertino, S., Pende, D., Balsamo, M., Pietra, G., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1052353 · Cited by 38
The dual-functional capability of cytokine-induced killer cells and application in tumor immunology
Zhang, Q., Liu, X.-Y., Zhang, T., Zhang, X., Zhao, L., Long, F., Liu, Z., & Wang, E. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.09.021 · Cited by 39
KIR+CD8+ and NKG2A+CD8+ T cells are distinct innate-like populations in humans
Choi, S. J., Koh, J., Rha, M., Seo, I., Lee, H., Jeong, S., Park, S., & Shin, E. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112236 · Cited by 37
Natural killer cells in aging and age-related diseases
Qi, C., & Liu, Q. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106156 · Cited by 41
Non-viral approaches in CAR-NK cell engineering: connecting natural killer cell biology and gene delivery
McErlean, E. M., & McCarthy, H. O. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02746-4 · Cited by 42
Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
Hardcastle, S. L., Brenu, E., Johnston, S., Nguyen, T. U., Huth, T. K., Ramos, S. B., Staines, D., & Marshall‐Gradisnik, S. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.12399 · Cited by 36
Current and Potential Uses of Immunocytokines as Cancer Immunotherapy
Sondel, P. M., & Gillies, S. D. (2012) · Antibodies · doi:10.3390/antib1020149 · Cited by 38
Daphnia magna shows reduced infection upon secondary exposure to a pathogen
McTaggart, S. J., Wilson, P. J., & Little, T. J. (2012) · Biology Letters · doi:10.1098/rsbl.2012.0581 · Cited by 37
Sodium selenite ameliorates dextran sulfate sodium-induced chronic colitis in mice by decreasing Th1, Th17, and γδT and increasing CD4(+)CD25(+) regulatory T-cell responses
Sang, L.-X., Chang, B., Zhu, J., Yang, F., Li, Y., Jiang, X., Wang, D., Lu, C., & Sun, X. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i21.3850 · Cited by 38
Decreased Human Leukocyte Antigen-G Expression by miR-133a Contributes to Impairment of Proinvasion and Proangiogenesis Functions of Decidual NK Cells
Guo, W., Fang, L., Li, B., Xiao, X., Chen, S., Wang, J., Yang, F., Chen, L., & Wang, X. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00741 · Cited by 37
A Batf3/Nlrp3/IL-18 Axis Promotes Natural Killer Cell IL-10 Production during Listeria monocytogenes Infection
Clark, S. E., Schmidt, R. L., McDermott, D. S., & Lenz, L. L. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.106 · Cited by 38
Treatment of advanced hepatocellular carcinoma: immunotherapy from checkpoint blockade to potential of cellular treatment
Siu, E. H.-L., Chan, A. W. H., Chong, C. C. N., Chan, S. L., Lo, K. W., & Cheung, S. (2018) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2018.10.16 · Cited by 37
Effect of miR-30e regulating NK cell activities on immune tolerance of maternal-fetal interface by targeting PRF1
Huang, Q., Ding, J., Gong, M., Wei, M., Zhao, Q., & Yang, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.172 · Cited by 37
Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process
Yazdi, A., Ghasemi‐Kasman, M., & Javan, M. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24509 · Cited by 38
New trends in cellular therapy
Okano, H., & Sipp, D. (2020) · Development · doi:10.1242/dev.192567 · Cited by 38
Immunological effect of irreversible electroporation on hepatocellular carcinoma
Guo, X., Du, F., Liu, Q., Guo, Y., Wang, Q., Huang, W., Wang, Z., Ding, X., & Wu, Z. (2021) · BMC Cancer · doi:10.1186/s12885-021-08176-x · Cited by 37
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies
Chen, X., Tan, B., Xing, H., Zhao, X., Ping, Y., Zhang, Z., Huang, J., Shi, X., Zhang, N., Lin, B., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03586-1 · Cited by 42
Insights into next-generation immunotherapy designs and tools: molecular mechanisms and therapeutic prospects
Qin, H., Zhou, Z., Shi, R., Mai, Y., Xu, Y., Fu, P., Cheng, G., Zhang, Z., Chen, W., Chen, Y., et al. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01701-6 · Cited by 43
Rapamycin Augments Human DC IL-12p70 and IL-27 Secretion to Promote Allogeneic Type1 Polarization Modulated by NK Cells
Macedo, C., Turnquist, H. R., Castillo‐Rama, M., Zahorchak, A. F., Shapiro, R., Thomson, A. W., & Metes, D. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12351 · Cited by 36
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias
Pietra, G., Vitale, C., Pende, D., Bertaina, A., Moretta, F., Falco, M., Vacca, P., Montaldo, E., Cantoni, C., Mingari, M. C., et al. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1744-y · Cited by 36
Self-citation
An Fc‐optimized NKG2D‐immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia
Steinbacher, J., Baltz‐Ghahremanpour, K., Schmiedel, B. J., Steinle, A., Jung, G., Kübler, A., Andre, M. C., Große‐Hovest, L., & Salih, H. R. (2014) · International Journal of Cancer · doi:10.1002/ijc.29083 · Cited by 35
Cell Mediators of Autoimmune Hepatitis and Their Therapeutic Implications
Montaño‐Loza, A. J., & Czaja, A. J. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3473-z · Cited by 38
Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3.
Golden‐Mason, L., Hurtado, C. W., Cheng, L., & Rosen, H. R. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.03.008 · Cited by 35
Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations
Maciejewski‐Duval, A., Meuris, F., Bignon, A., Aknin, M.-L. R., Balabanian, K., Faivre, L. O., Pasquet, M., Barlogis, V., Fieschi, C., Bellanné‐Chantelot, C., et al. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ma0815-388r · Cited by 36
Effects of Postoperative Pain Management on Immune Function After Laparoscopic Resection of Colorectal Cancer
Kim, S. Y., Kim, N. K., Baik, S. H., Min, B. S., Hur, H., Lee, J., Noh, H.-Y., Lee, J. H., & Koo, B. (2016) · Medicine · doi:10.1097/md.0000000000003602 · Cited by 36
Gut-liver axis: gut microbiota in shaping hepatic innate immunity
Wu, X., & Tian, Z. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9128-3 · Cited by 36
Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication
Zhao, D., Jiang, X., Xu, Y., Yang, H., Gao, D., Li, X., Gao, L., Ma, C., & Liang, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01124 · Cited by 36
Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 – Implications for Clinical Trials
TÖRNROOS, H., Hägerstrand, H., & Lindqvist, C. (2018) · Anticancer Research · doi:10.21873/anticanres.13085 · Cited by 36
The Immuno-Enhancement Effects of Tubiechong (Eupolyphaga sinensis) Lyophilized Powder in Cyclophosphamide-Induced Immunosuppressed Mice
Liu, H., Yan, Y.-L., Zhang, F., & Qiao-feng, W. (2019) · Immunological Investigations · doi:10.1080/08820139.2019.1588291 · Cited by 36
Functional and metabolic targeting of natural killer cells to solid tumors
Wang, J., & Matosevic, S. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00523-7 · Cited by 35
Role of the Bone Marrow Milieu in Multiple Myeloma Progression and Therapeutic Resistance
Ho, M., Goh, C. Y., Patel, A. S., Staunton, S., O’Connor, R., Godeau, M., & Bianchi, G. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2020.05.026 · Cited by 40
Interferon regulatory factor 1 (IRF-1) downregulates Checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in Hepatocellular carcinoma (HCC) cells
Yan, Y., Zheng, L., Du, Q., Cui, X., Dong, K., Guo, Y., & Geller, D. A. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01337-6 · Cited by 37
Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance
Martini, S., Gemma, A., Ferrari, M., Cosentino, M., & Marino, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043125 · Cited by 39
Expansion of NK cells from PBMCs using immobilized 4-1BBL and interleukin-21
Li, X., He, C., Liu, C., Ma, J., Ma, P., Cui, H., Tao, H., & Gao, B. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3005 · Cited by 36
Mechanisms for Size-Dependent Protein Segregation at Immune Synapses Assessed with Molecular Rulers
Alakoskela, J.-M. I., Koner, A. L., Rudnicka, D., Köhler, K., Howarth, M. R., & Davis, D. M. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.05.013 · Cited by 36
HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity
Peipp, M., Derer, S., Lohse, S., Staudinger, M., Klausz, K., Valerius, T., Gramatzki, M., & Kellner, C. (2015) · Oncotarget · doi:10.18632/oncotarget.5135 · Cited by 38
Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities
Roy, A. L., Prébet, T., Castellano, R., Goubard, A., Riccardi, F., Fauriat, C., Granjeaud, S., Benyamine, A., Castanier, C., Orlanducci, F., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00977 · Cited by 35
Loss of Canonical Notch Signaling Affects Multiple Steps in NK Cell Development in Mice
Cháves, P., Zriwil, A., Wittmann, L., Boukarabila, H., Peitzsch, C., Jacobsen, S. E. W., & Sitnicka, E. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701675 · Cited by 36
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria
Odera, D., Tuju, J., Mwai, K., Nkumama, I. N., Fürle, K., Chege, T., Kimathi, R., Diehl, S., Musasia, F. K., Rosenkranz, M., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn5993 · Cited by 32
NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer
Li, J., Hu, H., Lian, H., Yang, S., Liu, M., He, J., Cao, B., Chen, D. S., Hu, Y., Zhi, C., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.88539 · Cited by 39
Fc-Optimized NKG2D–Fc Constructs Induce NK Cell Antibody-Dependent Cellular Cytotoxicity against Breast Cancer Cells Independently of HER2/neu Expression Status
Maurer, S., Steinbacher, J., Schmiedel, B. J., Kousis, P. C., Steinle, A., Jung, G., Große‐Hovest, L., & Salih, H. R. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400872 · Cited by 35
SHIP1 Intrinsically Regulates NK Cell Signaling and Education, Resulting in Tolerance of an MHC Class I–Mismatched Bone Marrow Graft in Mice
Gumbleton, M., Vivier, É., & Kerr, W. G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402930 · Cited by 36
Cellular therapy of cancer with natural killer cells—where do we stand?
Klingemann, H. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.03.011 · Cited by 37
Identification of anti-viral cytotoxic effector cells in the ginbuna crucian carp, Carassius auratus langsdorfii
Somamoto, T., Nakanishi, T., & Nakao, M. (2012) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2012.11.001 · Cited by 35
Innate recognition of malarial parasites by mammalian hosts
Liehl, P., & Mota, M. M. (2012) · International Journal for Parasitology · doi:10.1016/j.ijpara.2012.04.006 · Cited by 37
Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers
Chang, Y.-J., & Huang, X.-J. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.19 · Cited by 35
Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis
Wild, J. S., Schmiedel, B. J., Maurer, A., Raab, S., Prokop, L., Stevanović, S., Dörfel, D., Schneider, P., & Salih, H. R. (2015) · Leukemia · doi:10.1038/leu.2015.50 · Cited by 35
Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination
Oth, T., Vanderlocht, J., van Elssen, C. H. M. J., Bos, G. M. J., & Germeraad, W. T. V. (2016) · Mediators of Inflammation · doi:10.1155/2016/5740373 · Cited by 36
Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Björklund, A. T., Clancy, T., Goodridge, J. P., Béziat, V., Schaffer, M., Hovig, E. J., Ljunggren, H., Ljungman, P. T., & Malmberg, K. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501434 · Cited by 35
Multiple Levels of Control Determine How E4bp4/Nfil3 Regulates NK Cell Development
Kostrzewski, T. M., Borg, A. J., Meng, Y., Filipovic, I., Male, V. H., Wack, A., DiMaggio, P. A., & Brady, H. J. M. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700981 · Cited by 37
Nano-Pulse Stimulation Ablates Orthotopic Rat Hepatocellular Carcinoma and Induces Innate and Adaptive Memory Immune Mechanisms that Prevent Recurrence
Lassiter, B. P., Guo, S., & Beebe, S. J. (2018) · Cancers · doi:10.3390/cancers10030069 · Cited by 36
IL-2 And IL-15 Induced NKG2D, CD158a and CD158b Expression on T, NKT- like and NK Cell Lymphocyte Subsets from Regional Lymph Nodes of Melanoma Patients
Vuletić, A. M., Jovanić, I., Jurišić, V., Milovanović, Z., Nikolić, S., Spurnić, I., & Konjević, G. M. (2018) · Pathology & Oncology Research · doi:10.1007/s12253-018-0444-2 · Cited by 35
Diversity of Killer Cell Immunoglobulin-Like Receptors and Disease
Rajalingam, R. (2018) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2018.08.001 · Cited by 35
Mechanisms of Natural Killer Cell Evasion Through Viral Adaptation
Mancini, M., & Vidal, S. M. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082619-124440 · Cited by 35
Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy
Islam, R., Pupovac, A., Evtimov, V. J., Boyd, N. R., Shu, R., Boyd, R. L., & Trounson, A. O. (2021) · Cells · doi:10.3390/cells10051058 · Cited by 35
“The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
Khoury, M., Cohen, I., & Bar‐Sela, G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020389 · Cited by 40
Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK‐cell repertoire in the French population
Gagne, K., Willem, C., Legrand, N., Djaoud, Z., David, G., Rettman, P., Bressollette‐Bodin, C., Senitzer, D., Esbelin, J., Cesbron‐Gautier, A., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201243007 · Cited by 35
Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study
La, D., Czarnecki, C., El-Gabalawy, H. S., Kumar, A., Meyers, A. F. A., Bastien, N., Simonsen, J. N., Plummer, F. A., & Luo, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029200 · Cited by 35
Organ-specific phenotypic and functional features of NK cells in humans
Sharma, R., & Das, A. (2013) · Immunologic Research · doi:10.1007/s12026-013-8477-9 · Cited by 35
Tim-3 Negatively Mediates Natural Killer Cell Function in LPS-Induced Endotoxic Shock
Hou, H., Liu, W., Wu, S., Lu, Y., Peng, J., Zhu, Y., Lu, Y., Wang, F., & Ziyong, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110585 · Cited by 38
Diesel exhaust particles modify natural killer cell function and cytokine release
Müller, L. L., Chehrazi, C., Henderson, M. W., Noah, T. L., & Jaspers, I. (2013) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-10-16 · Cited by 36
Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30
Kellner, C., Guenther, A., Humpe, A., Repp, R., Klausz, K., Derer, S., Valerius, T., Ritgen, M., Brüggemann, M., van de Winkel, J. G. J., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1058459 · Cited by 35
The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review
Désage, A.-L., Karpathiou, G., Peoc’h, M., & Froudarakis, M. E. (2021) · Cancers · doi:10.3390/cancers13133205 · Cited by 34
Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications
Siemaszko, J., Marzec-Przyszlak, A., & Bogunia‐Kubik, K. (2023) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-023-00674-z · Cited by 35
The role of peripheral immunity in ALS: a population‐based study
Grassano, M., Manera, U., Marchi, F. D., Cugnasco, P., Matteoni, E., Daviddi, M., Solero, L., Bombaci, A., Palumbo, F., Vasta, R., et al. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51853 · Cited by 34
Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV‐Infected Patients
Pan, Z., Wu, N., & Jin, C. (2023) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2023/3080969 · Cited by 36
Dietary fat without body weight gain increases in vivo MCF‐7 human breast cancer cell growth and decreases natural killer cell cytotoxicity
Lamas, B., Nachat, R., Gonçalves-Mendes, N., Mishellany, F., Rossary, A., Vasson, M., & Farges, M. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22074 · Cited by 34
Natural killer cell receptors: alterations and therapeutic targeting in malignancies
Konjević, G. M., Vuletić, A. M., & Martinović, K. M. (2015) · Immunologic Research · doi:10.1007/s12026-015-8695-4 · Cited by 36
Relapsed and Refractory Pediatric Acute Myeloid Leukemia: Current and Emerging Treatments
Davila, J. G., Slotkin, E. K., & Renaud, T. M. (2013) · Pediatric Drugs · doi:10.1007/s40272-013-0048-y · Cited by 35
Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation
Bisio, F., Bozzano, F. M., Marras, F., Biagio, A. D., Moretta, L., & Maria, A. D. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.03.003 · Cited by 34
Inborn errors of the development of human natural killer cells
Jouanguy, E., Gineau, L., Cottineau, J., Béziat, V., Vivier, É., & Casanova, J. (2013) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000011 · Cited by 34
Evaluation of NK Cell Function by Flowcytometric Measurement and Impedance Based Assay Using Real-Time Cell Electronic Sensing System
Park, K.-H., Park, H., Kim, M., Kim, Y., Han, K., & Oh, E. (2013) · BioMed Research International · doi:10.1155/2013/210726 · Cited by 34

Authors: Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S.
Affiliations: Centre d’Immunologie de Marseille-Luminy (CIML), Université de la Méditerranée UM 631, Campus de Luminy, 13288 Marseille, France.
University of California, Berkeley (US)
University of Genoa (IT)
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
Inserm (FR)
University of California, San Francisco (US)
Howard Hughes Medical Institute (US)
Centre National de la Recherche Scientifique (FR)
Corresponding author: Raulet, David H.
Moretta, Alessandro
Caligiuri, Michael A.
Zitvogel, Laurence
Lanier, Lewis L.
Yokoyama, Wayne M.
Ugolini, Sophie
ORCID: Raulet, David H.
Caligiuri, Michael A.
Zitvogel, Laurence
Lanier, Lewis L.
Yokoyama, Wayne M.
Ugolini, Sophie
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2011-01-07
Volume: 331
Issue: 6013
Pages: 44-49
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.1198687
PMC: PMC3089969
OpenAlex: W2146313292
Cited by: 2,824
References: 78
Citations by year: 2026: 133 · 2025: 147 · 2024: 158 · 2023: 142 · 2022: 215 · 2021: 211 · 2020: 222 · 2019: 205 · 2018: 176 · 2017: 211 · 2016: 176 · 2015: 191 · 2014: 199 · 2013: 200 · 2012: 150
FWCI: 17.62
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Science (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
HAL (submittedVersion)
CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
Funders: Howard Hughes Medical Institute
National Cancer Institute (R01CA093678, R01CA095137, P01CA095426, CA095137, CA16058, CA 68458, CA95426, CA093678, P30CA016058)
National Institute of Allergy and Infectious Diseases (AI-068129, R01AI068129, AI51345, R37AI066897, AI039642, AI34385, R01AI033903, AI5716, R01AI051345, AI-33903, R01AI039642, AI066897, R01AI035021, AI035021, P30AI027763)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords: natural killer cells, innate immunity, adaptive immunity, NK cell receptors, activating and inhibitory receptors, self-tolerance, cytotoxicity, viral infection, antitumor immunity, immunological memory
MeSH terms: Animals, Humans, Immunity, Innate, Immunologic Memory, Killer Cells, Natural, Neoplasms, Receptors, Immunologic, Virus Diseases, Self Tolerance, Adaptive Immunity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Innate or Adaptive Immunity? The Example of Natural Killer Cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks